Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
General Pulmonary
Do the following guidelines influence your approach to prescribing antibacterial coverage for viral pneumonia?
https://www.atsjournals.org/doi/10.1164/rccm.202507-1692ST
Related Questions
What are your vaccine recommendations while patients are on biologics?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
Do you utilize cytokine panels to guide treatment of patients with EGPA?
When interpreting pulmonary function tests, do you routinely distinguish between hyperinflation and gas trapping?
Do you have any tips for effectively performing EBUS with biopsy at the 4L lymph node station?
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
How do you mitigate risk when performing bronchoscopy in hypoxic patients requiring high levels of supplemental oxygen?
How would you manage an intermediate-risk segmental PE that is transiently provoked after a knee surgery?
Do you have any strategies to increase yield while doing a BAL?
What is the minimum daily duration of supplemental oxygen therapy you recommend to patients with chronic hypoxic respiratory failure?
